The Valens Company with Everett Knight EVP, Corporate Development & Capital Markets. Our next guest works at the largest publicly traded extraction company in the world with a broad expanding international footprint. HealthEuropa recently described The Valens Company as “one of the few companies in the world that can facilitate the utilization of five extraction techniques using customized and proprietary methods and technology, with further research and development always ongoing. This flexibility and technical expertise allow The Valens Company to produce almost any cannabis product imaginable, which means its clients can make their vision of a unique and differentiated cannabis-infused product a reality". When talking about building a brand, our guest believes the main goal for any company is to achieve profitability. Everett said this about what was attributed to Valens’ success in achieving profitability. Everett's team recently announced its participation in a Medical Cannabis Real-World Evidence Study (the "MC-RWE Study") led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada.
Enjoy this episode?
Subscribe to Blunt Business for new episodes.
More from Blunt Business
A Psychedelic and Cannabis Research Revolution On the Horizon?
Blunt Business
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.